Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-155969

Options or other derivatives

  • Chief Operating Officer acquired 72,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Powala Christopher · Chief Operating Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2016-12-15 Grant or award : show line 1 in the form Stock option (right to buy) +62,400 62,400 D
2016-12-15 Grant or award : show line 2 in the form Restricted stock units +10,400 10,400 D
Loading xslF345X03/doc4.xml…